LTB4_20-hydroxy structure
|
Common Name | LTB4_20-hydroxy | ||
|---|---|---|---|---|
| CAS Number | 79516-82-8 | Molecular Weight | 352.465 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 581.8±50.0 °C at 760 mmHg | |
| Molecular Formula | C20H32O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 319.7±26.6 °C | |
Use of LTB4_20-hydroxy20-Hydroxy-leukotriene B4 is an endogenous metabolite present in Urine that can be used for the research of Sjogren Larsson Syndrome[1][2]. |
| Name | (5s,12r)-5,12,20-trihydroxy-(6z,8e,10e,14z)-eicosatetraenoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | 20-Hydroxy-leukotriene B4 is an endogenous metabolite present in Urine that can be used for the research of Sjogren Larsson Syndrome[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite |
| In Vitro | Endogenous metabolites is defined as those that are annotated by Kyoto Encyclopedia of Genes and Genomes as substrates or products of the ~1900 metabolic enzymes encoded in our genome. It is clear in the body of literature that there are documented toxic properties for many of these metabolites[1]. |
| References |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 581.8±50.0 °C at 760 mmHg |
| Molecular Formula | C20H32O5 |
| Molecular Weight | 352.465 |
| Flash Point | 319.7±26.6 °C |
| Exact Mass | 352.224976 |
| PSA | 97.99000 |
| LogP | 2.05 |
| Vapour Pressure | 0.0±3.7 mmHg at 25°C |
| Index of Refraction | 1.542 |
| Hazard Codes | F: Flammable;Xi: Irritant; |
|---|---|
| Risk Phrases | 11-36/37/38 |
| Safety Phrases | 16-26-36 |
| RIDADR | UN 1170 3/PG 2 |
| 20-hydroxy-leukotriene B4 |
| 20-Hydroxy-LTB4 |
| 20-hydroxyleukotriene |
| hydroxyleukotriene B4 |
| (5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxy-6,8,10,14-icosatetraenoic acid |
| LTB4_20-hydroxy |
| 20-OH-LTB4 |
| 5S,12R,20-TRIHYDROXY-6Z,8E,10E,14Z-EICOSATETRAENOIC ACID |
| 6,8,10,14-Eicosatetraenoic acid, 5,12,20-trihydroxy-, (5S,6Z,8E,10E,12R,14Z)- |
| MFCD00065858 |